Provided by Tiger Trade Technology Pte. Ltd.

CVS Health

93.93
+0.87000.93%
Volume:1.92M
Turnover:179.75M
Market Cap:120.38B
PE:24.61
High:93.97
Open:93.45
Low:92.86
Close:93.06
52wk High:110.68
52wk Low:69.51
Shares:1.28B
Float Shares:1.27B
Volume Ratio:0.51
T/O Rate:0.15%
Dividend:2.66
Dividend Rate:2.83%
EPS(TTM):3.82
EPS(LYR):1.39
ROE:6.21%
ROA:2.97%
PB:1.51
PE(LYR):67.58

Loading ...

Movement Alert|CVS Health Falls 3.02% in Regular Trading, Forward Business Warning Aftershocks Continue to Weigh on Stock

Market Focus
·
Aug 17

How Investors May Respond To CVS (CVS) Earnings Upgrade And Expanded GLP-1 Weight Loss Platform

Simply Wall St.
·
Aug 15

Viking Global Dissolves Stake in Apple, Alphabet

Reuters
·
Aug 15

CVS Health Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 15

Mubadala Investment Co Pjsc Reports Share Stake in Ford Motor, Phillips 66, Dissolves in Apple

Reuters
·
Aug 14

CVS Health (CVS) Stock Trades Below Fair Value After A 48% Gain

Simply Wall St.
·
Aug 13

Bernstein Keeps Their Buy Rating on CVS Health (CVS)

TIPRANKS
·
Aug 13

CVS Caremark Survey Shows 91% of Employers Worry About Rising Prescription Drug Prices

Reuters
·
Aug 12

Alight Names Jodi Bryant SVP of Consultant, Broker Relationships

Reuters
·
Aug 12

CVS Health is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 12

JPMorgan Adjusts Price Target on CVS Health to $118 From $111, Keeps Overweight Rating

MT Newswires Live
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

CVS Health Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)

TIPRANKS
·
Aug 11

CVS Health: Buy Rating Reaffirmed as Strong Earnings Outlook and Segment Outperformance Support Unchanged $110 Price Target

TIPRANKS
·
Aug 10

CVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed?

Simply Wall St.
·
Aug 07

CVS Health: Buy Rating Reiterated as Strong Q2 Results Support Raised Guidance; Price Target Maintained at $106

TIPRANKS
·
Aug 06

UBS Adjusts Price Target on CVS Health to $126 From $122, Maintains Buy Rating

MT Newswires Live
·
Aug 06

CVS Group CFO Increases Stake with On‑Market Share Purchase

TIPRANKS
·
Aug 06

CVS Health is Maintained at Overweight by Barclays

Dow Jones
·
Aug 06